nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Bronchospasm—Bleomycin—germ cell cancer	0.039	0.039	CcSEcCtD
Bromhexine—Bronchospasm—Ifosfamide—germ cell cancer	0.0333	0.0333	CcSEcCtD
Bromhexine—Bronchospasm—Etoposide—germ cell cancer	0.0263	0.0263	CcSEcCtD
Bromhexine—Immune system disorder—Ifosfamide—germ cell cancer	0.0245	0.0245	CcSEcCtD
Bromhexine—Anaphylactic shock—Bleomycin—germ cell cancer	0.0226	0.0226	CcSEcCtD
Bromhexine—Angioedema—Ifosfamide—germ cell cancer	0.0216	0.0216	CcSEcCtD
Bromhexine—Immune system disorder—Cisplatin—germ cell cancer	0.0211	0.0211	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.02	0.02	CcSEcCtD
Bromhexine—Hypersensitivity—Vinblastine—germ cell cancer	0.0197	0.0197	CcSEcCtD
Bromhexine—Immune system disorder—Etoposide—germ cell cancer	0.0194	0.0194	CcSEcCtD
Bromhexine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.0193	0.0193	CcSEcCtD
Bromhexine—Skin disorder—Ifosfamide—germ cell cancer	0.0187	0.0187	CcSEcCtD
Bromhexine—Diarrhoea—Vinblastine—germ cell cancer	0.0183	0.0183	CcSEcCtD
Bromhexine—Urticaria—Bleomycin—germ cell cancer	0.0179	0.0179	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.0172	0.0172	CcSEcCtD
Bromhexine—Vomiting—Vinblastine—germ cell cancer	0.017	0.017	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.0166	0.0166	CcSEcCtD
Bromhexine—Anaphylactic shock—Cisplatin—germ cell cancer	0.0166	0.0166	CcSEcCtD
Bromhexine—Hypersensitivity—Bleomycin—germ cell cancer	0.0166	0.0166	CcSEcCtD
Bromhexine—Skin disorder—Cisplatin—germ cell cancer	0.0161	0.0161	CcSEcCtD
Bromhexine—Pruritus—Bleomycin—germ cell cancer	0.016	0.016	CcSEcCtD
Bromhexine—Nausea—Vinblastine—germ cell cancer	0.0159	0.0159	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0158	0.0158	CcSEcCtD
Bromhexine—Hypersensitivity—Dactinomycin—germ cell cancer	0.0155	0.0155	CcSEcCtD
Bromhexine—Urticaria—Ifosfamide—germ cell cancer	0.0153	0.0153	CcSEcCtD
Bromhexine—Anaphylactic shock—Etoposide—germ cell cancer	0.0152	0.0152	CcSEcCtD
Bromhexine—Skin disorder—Etoposide—germ cell cancer	0.0148	0.0148	CcSEcCtD
Bromhexine—Diarrhoea—Dactinomycin—germ cell cancer	0.0144	0.0144	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.0143	0.0143	CcSEcCtD
Bromhexine—Vomiting—Bleomycin—germ cell cancer	0.0143	0.0143	CcSEcCtD
Bromhexine—Rash—Bleomycin—germ cell cancer	0.0142	0.0142	CcSEcCtD
Bromhexine—Dermatitis—Bleomycin—germ cell cancer	0.0142	0.0142	CcSEcCtD
Bromhexine—Hypersensitivity—Ifosfamide—germ cell cancer	0.0142	0.0142	CcSEcCtD
Bromhexine—Pruritus—Ifosfamide—germ cell cancer	0.0136	0.0136	CcSEcCtD
Bromhexine—Nausea—Bleomycin—germ cell cancer	0.0134	0.0134	CcSEcCtD
Bromhexine—Vomiting—Dactinomycin—germ cell cancer	0.0134	0.0134	CcSEcCtD
Bromhexine—Rash—Dactinomycin—germ cell cancer	0.0133	0.0133	CcSEcCtD
Bromhexine—Diarrhoea—Ifosfamide—germ cell cancer	0.0132	0.0132	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.0131	0.0131	CcSEcCtD
Bromhexine—Nausea—Dactinomycin—germ cell cancer	0.0125	0.0125	CcSEcCtD
Bromhexine—Vomiting—Ifosfamide—germ cell cancer	0.0123	0.0123	CcSEcCtD
Bromhexine—Hypersensitivity—Cisplatin—germ cell cancer	0.0122	0.0122	CcSEcCtD
Bromhexine—Rash—Ifosfamide—germ cell cancer	0.0122	0.0122	CcSEcCtD
Bromhexine—Dermatitis—Ifosfamide—germ cell cancer	0.0121	0.0121	CcSEcCtD
Bromhexine—Urticaria—Etoposide—germ cell cancer	0.0121	0.0121	CcSEcCtD
Bromhexine—Immune system disorder—Methotrexate—germ cell cancer	0.0116	0.0116	CcSEcCtD
Bromhexine—Nausea—Ifosfamide—germ cell cancer	0.0114	0.0114	CcSEcCtD
Bromhexine—Diarrhoea—Cisplatin—germ cell cancer	0.0114	0.0114	CcSEcCtD
Bromhexine—Hypersensitivity—Etoposide—germ cell cancer	0.0112	0.0112	CcSEcCtD
Bromhexine—Pruritus—Etoposide—germ cell cancer	0.0108	0.0108	CcSEcCtD
Bromhexine—Vomiting—Cisplatin—germ cell cancer	0.0106	0.0106	CcSEcCtD
Bromhexine—Rash—Cisplatin—germ cell cancer	0.0105	0.0105	CcSEcCtD
Bromhexine—Dermatitis—Cisplatin—germ cell cancer	0.0105	0.0105	CcSEcCtD
Bromhexine—Diarrhoea—Etoposide—germ cell cancer	0.0104	0.0104	CcSEcCtD
Bromhexine—Nausea—Cisplatin—germ cell cancer	0.00987	0.00987	CcSEcCtD
Bromhexine—Vomiting—Etoposide—germ cell cancer	0.00968	0.00968	CcSEcCtD
Bromhexine—Rash—Etoposide—germ cell cancer	0.0096	0.0096	CcSEcCtD
Bromhexine—Dermatitis—Etoposide—germ cell cancer	0.00959	0.00959	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00945	0.00945	CcSEcCtD
Bromhexine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00912	0.00912	CcSEcCtD
Bromhexine—Nausea—Etoposide—germ cell cancer	0.00904	0.00904	CcSEcCtD
Bromhexine—Skin disorder—Methotrexate—germ cell cancer	0.00886	0.00886	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00787	0.00787	CcSEcCtD
Bromhexine—Urticaria—Methotrexate—germ cell cancer	0.00724	0.00724	CcSEcCtD
Bromhexine—Hypersensitivity—Methotrexate—germ cell cancer	0.00672	0.00672	CcSEcCtD
Bromhexine—Pruritus—Methotrexate—germ cell cancer	0.00645	0.00645	CcSEcCtD
Bromhexine—Diarrhoea—Methotrexate—germ cell cancer	0.00624	0.00624	CcSEcCtD
Bromhexine—Vomiting—Methotrexate—germ cell cancer	0.0058	0.0058	CcSEcCtD
Bromhexine—Rash—Methotrexate—germ cell cancer	0.00575	0.00575	CcSEcCtD
Bromhexine—Dermatitis—Methotrexate—germ cell cancer	0.00574	0.00574	CcSEcCtD
Bromhexine—Nausea—Methotrexate—germ cell cancer	0.00542	0.00542	CcSEcCtD
